CellFE and Made Scientific Announce Strategic Collaboration to Advance Non-viral Gene Editing for T Cell Therapies
CellFE and Made Scientific announce a strategic collaboration to generate pilot data on the CellFE High Volume Cyva™ System.
News
Categories
CellFE Partners with DKFZ and TcellTech to Advance DNA Vector Genetic Engineering for Cellular Therapies
CellFE, a leader in non-viral gene editing technology, announces a strategic collaboration with the Harbottle Lab at German Cancer Research Center (DKFZ) and its spin-out company, TcellTech.
Application Note: Efficient Gene Editing of iPSCs
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing.
CellFE Announces Launch of First-in-Class T-Rest (“Resting T Cell Kit”) for Breakthrough CAR-T Cell Therapy Manufacturing
CellFE® today announced the launch of its highly anticipated CellFE T-Rest™, a first-in-class cell manufacturing transfection media product designed specifically for resting T cell workflows, along with an app note.
CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
CellFE Appoints Mike Rice to Board of Directors
CellFE Announces Presentations at International Society of Gene & Cell Therapy (ISCT) 2024 Annual Meeting
CellFE announced today an upcoming presentation by CEO Alla Zamarayeva, PhD, at the International Society of Gene & Cell Therapy (ISCT) Annual Meeting, taking place May 29-June 1, 2024 in Vancouver, BC.
CellFE Announces May 2024 Conference Presentations
CellFE announced today an upcoming presentation by CSO Todd Sulchek, PhD, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 7-11, 2024 in Baltimore, MD.
CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform
CellFE announced the completion of a $22 million Series A financing led by M Ventures, with participation from Great Point Ventures, Riverine Ventures and its existing investors.
CellFE Closes Series Seed Funding Round
CellFE announced it has raised $3.6 million in an initial Series Seed, co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures.